Kari Myren
Tracked across 1 events · 6 articles · First seen Aug 11, 2026 · Last active Aug 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Kari Myren is the Chief Medical Officer at Oncoinvent and is quoted in the announcement. Her statements reinforce the safety and development potential of Radspherin.
Aug 11, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Kari Myren live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard